Mayo Clinic Researchers Publish Critical Study: Antifibrotics Can Extend Lives for IPF Patients
PR Log,
Historically, patients with idiopathic pulmonary fibrosis have grim outcomes when hospitalized.
Historically, patients with idiopathic pulmonary fibrosis have grim outcomes when hospitalized.
Sources: Mayo Clinic, Three Lakes Foundation Mayo Clinic researchers have revealed that patients who are taking antifibrotic…
Mayo Clinic researchers have revealed that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF…